rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Dcgi Singh

Rediff.com  »  News  »   Dcgi Singh

  News for Dcgi Singh

  • Business

Why is Novartis likely to lose Tiamulin drug licence?

Swiss drug maker Novartis is likely to face legal action for allegedly faking documents to seek registration of its veterinary product Tiamulin Hydrogen Fumarate (80 per cent granules) in India.......

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

The concerns surrounding drug manufacturing practices in India appear to have reached foreign shores, beyond the international regulators’ domain.  Ranbaxy whistle-blower Dinesh Thakur,......

Keep us in loop before any FDA swoop, India tells US

Inspections only in domestic authorities’ presence, visiting US drug regulator told Taking a tough stand on the ongoing regulatory issues faced by the domestic pharmaceutical industry because......

After ban on drug facilities, US regulator comes calling

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt,......

Biocon contests Roche claims on cancer drug

Biocon has lashed out at Roche a day after the Swiss company secured an order from the Delhi High Court barring the Indian company from marketing its new drug, co-developed with Mylan, as a......
  Web results for Dcgi Singh
Drug regulator maps out new site inspection norms for safer medicines

NEW DELHI:The Central Drug Standard Control Organisation ( CDSCO ) is drawing up a new inspection model for pharmaceutical manufacturing sites that... ...

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-regulator-maps-out-new-site-inspection-norms-for-safer-medicines/articleshow/52512488.cms
FIPO asks DCGI to furnish report of actions taken by SLAs on cancellation of licence to Mesalamine USP 800 mg tablet

The Federation of Indian Pharmacist Organisations (FIPO), in an RTI application, has demanded to DCGI Dr G N Singh to divulge the report of actions... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=95216&sid=1
Indian drug regulator to engage closely with pharma units on good manufacturing

The second week of May - 9th to 14th - marked an important shift in the way the Indian drug regulator is starting to view, monitor and engage with... ...

http://www.businesstoday.in/sectors/pharma/drug-regulator-to-engage-with-pharma-units-on-manufacturing/story/232643.html
Cipla, Macleod's, Ipca Labs face the heat for substandard drugs

The drugs of India's leading pharmaceutical companies such as Cipla, Macleods Pharma, Sanofi India and Ipca Labs have been found by India's drug... ...

http://www.ibtimes.co.in/cipla-macleods-ipca-labs-face-heat-substandard-drugs-678641
4 batches of substandard 'Combiflam' recalled

The Central drug regulator has ordered withdrawal of four batches of popular painkiller Combiflam from the market after finding them to be... ...

http://timesofindia.indiatimes.com/life-style/health-fitness/health-news/4-batches-of-substandard-Combiflam-recalled/articleshow/52250297.cms

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z